A column taking a closer look at the latest scientific progress surrounding SARS-CoV-2.
The Latest:
Covid-19 Vaccines or Natural Immunity – Do Both Protect?
September 10, 2021
Dr. Christian Bréchot
President, Global Virus Network
Professor, University of South Florida
In my role as USF Professor and President of the Global Virus Network (GVN), I will work with Linman Li, GVN Vice President, to update you biweekly on new findings about the coronavirus pandemic disrupting our lives.
Latest Post:
Back to School: Children and COVID-19
Get a closer look at what some prominent GVN scientists are working on.
Now Featuring:
Dr. Roman Chicz
Global Project Head, Recombinant COVID Vaccine Project
Sanofi
GVN is holding a webinar series for COVID-19 related science sharing, featuring expert virologists from GVN Centers of Excellence around the world. The topics will focus on different aspects of the virus and the ongoing efforts to combat it, highlighting the latest scientific progress. Each session will be a 30-minute live presentation, followed by a 20-minute Q&A period hosted by GVN President Dr. Christian Brechot.
Upcoming Webinar: Coming Soon!
The Nipah Virus (NiV) Explained
The Eurasia Review, September 8, 2021
State trying its best to get IAV functional soon: CM
The Hindu, India, September 8, 2021
Nipah virus vs Coronavirus: Symptoms, treatment and other details you need to know
DNA, India, September 7, 2021
EXPLAINED: Less Infectious Than Covid, But More Lethal. Here’s Why Nipah Has Kerala On Its Toes
News18, India, September 6, 2021
What is ‘Mu Variant’ of COVID-19? WHO Classifies It as Variant of Interest, May Be More Resistant to Vaccines [Details]
International Business Times, India, September 4, 2021
Read what GVN Members from our Centers of Excellence and Affiliates are doing to combat the virus, as well as updates from industry efforts and the latest SARS-CoV-2 News.